Mednet Reports
PRIORITY PRESS - ECCO-17 - 38th ESMO Multidisciplinary Congress
Targeted Therapies in Metastatic GIST and CRC
Amsterdam, The Netherlands / September 27-October 1, 2013
Amsterdam - Gastrointestinal stromal tumors (GIST) are a rare but treatable soft tissue sarcoma. Unlike other gastrointestinal cancers, more than 85% of GISTs express the KIT oncogene. Treatments that target the tyrosine kinase activity of...
PHYSICIAN PERSPECTIVE - Viewpoint based on presentations from the ECCO-17 - 38th ESMO Multidisciplinary Congress
LHRH Agonism vs. LHRH Antagonism: Cardiovascular Disease Difference Now Documented in Large Pooled Analysis
Amsterdam, The Netherlands / September 27-October 1, 2013
Guest Editor: Dr. Pierre I. Karakiewicz, MDUrologic Oncologist, Associate Professor and Senior Outcomes Research ScientistDirector, Cancer Prognostics and Health Outcomes UnitUniversity of Montreal Health...
MEDICAL FRONTIERS - XXI World Congress of Neurology
Early Intervention and a Tailored Approach: Opportunity for Improved Disease Control in the Management of Relapsing-Remitting Multiple Sclerosis
Vienna, Austria / September 21-26, 2013
Vienna - Of all patients diagnosed with multiple sclerosis (MS), 90% will have relapsing-remitting multiple sclerosis (RRMS), the other 10% having a primary progressive form of the disease. Without treatment, approximately half of patients...
PRIORITY PRESS - 53rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
Staying Ahead of the Resistance Curve: Current and Future Strategies for More Effective Infection Control
Denver, Colorado / September 10-13, 2013
Denver - Staying ahead of the resistance curve has never been more challenging in the management of acute and chronic infections. In the past few decades, there has been a remarkable increase in resistance to current antibiotics. As new...
PRIORITY PRESS - European Respiratory Society (ERS) Annual Congress 2013
Emerging Bronchodilation Strategies for Improved COPD Control and Progression
Barcelona, Spain / September 7-11, 2013
Barcelona - In the treatment algorithm for chronic obstructive pulmonary disease (COPD), the early combination of bronchodilators is expected to be moved forward in guideline-based treatment. In the GOLD (Global Initiative for Chronic...
PRIORITY PRESS - European Respiratory Society (ERS) Annual Congress 2013
COPD Moves Toward Individualization of Care: Based on Need to Maximize Treatment Options
Barcelona, Spain / September 7-11, 2013
Barcelona - Based on a survey presented as a latebreaking presentation at the 2013 ERS, almost all specialists in chronic obstructive pulmonary disease (COPD) are aware of the GOLD (Global Initiative for Chronic Obstructive Lung Disease)...
MEDICAL FRONTIERS - European Respiratory Society (ERS) Annual Congress 2013
New Treatment Options in Pulmonary Arterial Hypertension Appear to Move Treatment Goals Beyond Symptom Control
Barcelona, Spain / September 7-11, 2013
Barcelona - New data presented at the ERS 2013 from trials published just weeks before the meeting was convened, document a paradigm shift in the treatment of pulmonary hypertension. In pulmonary arterial hypertension, the benefit of a new...
PRIORITY PRESS - 35th Annual Congress of the European Society of Cardiology (ESC)
Phase III Trials in Pulmonary Arterial Hypertension Focus on Clinical Events Rather Than Symptom Control
Amsterdam, Netherlands / August 31-September 4, 2013
Amsterdam - In pulmonary arterial hypertension (PAH), trials are being increasingly designed to evaluate protection against disease progression rather than symptom control alone, according to data presented at the 2013 ESC. The trial data...
PRIORITY PRESS - 35th Annual Congress of the European Society of Cardiology (ESC)
Vascular Outcomes Trials Confirm Safety of DPP-4 Inhibitors for the Treatment of Type 2 Diabetes Mellitus
Amsterdam, Netherlands / August 31-September 4, 2013
Amsterdam - Both of the first two trials in a series to confirm the cardiovascular safety of dipeptidyl peptidase-4 (DPP-4) inhibitors met their primary end point. Although there are important differences in the design and information...
MEDI-NEWS - Based on Lancet 2013;381(9869):825-35.
Invasive Meningococcal Disease in Infants: Immunogenicity and Safety of a Novel Multi-Component Serogroup B Vaccine
Serogroup B is now the dominant cause of invasive meningococcal disease (IMD) in Canada where it disproportionally affects infants. This underscores the importance of having an effective vaccine for this vulnerable age group. A...
